Search for: "Par Pharmaceutical"
Results 121 - 140
of 303
Sorted by Relevance
|
Sort by Date
24 Dec 2019, 6:00 am
” The DEA database “attributes the vast majority of the 76 billion opioid pills produced and shipped from 2006 through 2012 to three companies that are now controlled by large multinational drugmakers: SpecGx, a subsidiary of Ireland-based Mallinckrodt; Par Pharmaceutical, owned by Endo Pharmaceuticals, also in Ireland; and Actavis, part of Israel-based Teva Pharmaceutical Industries. [read post]
17 Jan 2018, 1:25 pm
Novartis Pharmaceuticals Corporation, S233898).Le devoir de diligence est une des conditions centrales de l'obligation de réparer un dommage en responsabilité civile. [read post]
13 Jul 2018, 1:57 pm
Hebei Welcome Pharmaceutical Co., Docket No. 16-1220, J. [read post]
10 Nov 2011, 9:23 pm
Official Liquidator of Esskay Pharmaceuticals Ltd., the SCI (G.S. [read post]
3 Dec 2009, 2:41 pm
The position is on par with the nation's drug czar. [read post]
3 Apr 2013, 6:19 pm
If the clinic is a Medicare par provider, they cannot balance bill, so their choice is to stop treating patients or take a loss. [read post]
7 Feb 2013, 10:50 am
Par Pharmaceutical, Inc., 694 F.3d 1344, 1351 (Fed. [read post]
28 Apr 2013, 9:00 pm
Ces caractéristiques sont couramment utilisées dans la technique et donc compréhensibles par l'homme du métier. [read post]
12 Feb 2015, 10:27 am
” Moore attributed part of the problem to the way pharmaceutical marketing has changed since 2001. [read post]
19 Jul 2013, 2:03 pm
Par. 29. [read post]
22 Apr 2009, 6:14 am
., a specialty pharmaceutical company, reported Christine Caufield in an April 17, 2009 article posted on Law360.com. [read post]
10 Nov 2011, 9:23 pm
Official Liquidator of Esskay Pharmaceuticals Ltd., the SCI (G.S. [read post]
4 May 2011, 10:36 am
29 Mar 2011, 9:19 pm
Merck (Kluwer Patent Blog) Keppra (Levetiracetam) – US: Orange Book patent listing precipitates DJ action to trigger generic Keppra XR 180-day exclusivity forfeiture: Par Pharmaceutical v UCB et al (FDA Law Blog) (Patent Docs) Naropin (Ropivacaine) – US: Judge O’Malley in dissent: Patent assignments should be a matter of state law: Abraxis BioScience v. [read post]
5 Apr 2011, 2:35 pm
Par Pharmaceutical, Inc. [read post]
26 Apr 2010, 7:56 am
Par Pharmaceutical, Inc., C.A. [read post]
27 Jul 2007, 5:05 am
Par and J&J announced they have settled their generic Ultracet patent litigation: MarketWatch; Patent Docs. [read post]
20 May 2013, 7:00 am
For all of this, the company pleaded guilty to producing sub-par products and making false statements to the FDA. [read post]
4 May 2011, 12:33 am
To the surprise of absolutely no one, the U.S. has again placed Canada on its Special 301 Priority Watch List, implausibly claiming that Canada's intellectual property laws are seriously deficient and on par with countries such as China and Russia. [read post]
28 Sep 2010, 3:14 pm
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
